Blue Jet Healthcare Limited (NSE:BLUEJET)

Market Cap	76.87B
Revenue (ttm)	11.79B
Net Income (ttm)	3.52B
Shares Out	173.47M
EPS (ttm)	20.31
PE Ratio	21.82
Forward PE	21.77
Dividend	1.20 (0.26%)
Ex-Dividend Date	Sep 19, 2025

Volume	39,545
Average Volume	239,491
Open	448.95
Previous Close	443.15
Day's Range	447.35 - 458.20
52-Week Range	441.00 - 1,027.80
Beta	0.33
RSI	20.71
Earnings Date	Feb 4, 2026

About Blue Jet Healthcare

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norw...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1968
• Employees: 196
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BLUEJET

Financial Performance

In 2024, Blue Jet Healthcare's revenue was 10.30 billion, an increase of 44.74% compared to the previous year's 7.12 billion. Earnings were 3.05 billion, an increase of 86.38%.